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Previewsproduction needed to maintain long term
cell survival. Hence, O’Sullivan et al.
have not only uncovered an interesting
observation for the burgeoning field of
immunometabolism but also raised stim-
ulating questions for biochemists to think
about regulation of metabolic pathways.
Specifically, biochemists will have to
incorporate futile metabolic pathways in
trying to understand how nutrients fulfill
the metabolic demands of cells.
REFERENCES
Chang, C.H., Curtis, J.D., Maggi, L.B., Jr., Faubert,
B., Villarino, A.V., O’Sullivan, D., Huang, S.C., vander Windt, G.J., Blagih, J., Qiu, J., et al. (2013).
Cell 153, 1239–1251.
Foster, D.W. (2012). J. Clin. Invest. 122, 1958–
1959.
MacIver, N.J., Michalek, R.D., and Rathmell, J.C.
(2013). Annu. Rev. Immunol. 31, 259–283.
Menendez, J.A., and Lupu, R. (2007). Nat. Rev.
Cancer 7, 763–777.
Michalek, R.D., Gerriets, V.A., Jacobs, S.R., Mac-
intyre, A.N., MacIver, N.J., Mason, E.F., Sullivan,
S.A., Nichols, A.G., and Rathmell, J.C. (2011).
J. Immunol. 186, 3299–3303.
O’Sullivan, D., van der Windt, G.J.W., Huang,
S.C.-C., Curtis, J.D., Chang, C.-H., Buck,
M.D., Qiu, J., Smith, A.M., Lam, W.Y., DiPlato,ImmuL.M., et al. (2014). Immunity 41, this issue,
75–88.
Pearce, E.L., Poffenberger,M.C., Chang, C.H., and
Jones, R.G. (2013). Science 342, 1242454.
Sena, L.A., Li, S., Jairaman, A., Prakriya, M.,
Ezponda, T., Hildeman, D.A., Wang, C.R., Schu-
macker, P.T., Licht, J.D., Perlman, H., et al.
(2013). Immunity 38, 225–236.
van der Windt, G.J., Everts, B., Chang, C.H., Cur-
tis, J.D., Freitas, T.C., Amiel, E., Pearce, E.J., and
Pearce, E.L. (2012). Immunity 36, 68–78.
Wang, R., Dillon, C.P., Shi, L.Z., Milasta, S., Carter,
R., Finkelstein, D., McCormick, L.L., Fitzgerald, P.,
Chi, H., Munger, J., and Green, D.R. (2011).
Immunity 35, 871–882.Regulatory T Cells: Exosomes Deliver ToleranceTalal A. Chatila1,* and Calvin B. Williams2
1Division of Immunology, the Children’s Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA
2Section of Rheumatology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
*Correspondence: talal.chatila@childrens.harvard.edu
http://dx.doi.org/10.1016/j.immuni.2014.07.001
T regulatory (Treg) cells enforce peripheral tolerance through regulation of diverse immune responses in a
context-specific manner. Okoye et al. show one way that Treg cells suppress Th1 cell responses is through
nonautonomous gene silencing mediated by microRNA-containing exosomes.T regulatory (Treg) cells employ a diverse
set of mechanisms to enforce peripheral
tolerance, reflecting both the complexity
and plasticity of immune responses.
Mechanisms of suppression include pro-
duction of immunomodulatory cytokines
(e.g., interleukin-10 [IL-10], transforming
growth factor-b [TGF-b], IL-35), the
expression of inhibitory receptors (cyto-
toxic T lymphocyte antigen 4 [CTLA-4]),
cytokine sinks (e.g., IL-2 receptor a
chain), direct cytotoxic killing (granzymes,
perforin), and several others (Shevach,
2009). These mechanisms have been
validated by the identification of human
and murine genetic defects that disable
individual pathways, leading to immune
dysregulation and autoimmunity. More
recently, context-specific inhibition has
emerged as a strategy to finely tune the
regulation of specific T helper cell
responses. Treg cells appropriate partial
or ‘‘aborted’’ forms of the transcriptionalprograms of respective target T helper
(Th) cell types by expressing their master
transcription factors and coopting their
function (Chaudhry et al., 2009; Zheng
et al., 2009). For example, in the case of
a Th1 cell response, Treg cells upregulate
the expression of T-bet, which in turn in-
duces the expression of some Th1-cell-
related genes such as CX3CR1 but not
others, enabling Treg cells to migrate to
sites of Th1-cell-mediated inflammation
while restraining their differentiation into
Th1 cells (Koch et al., 2012).
In this issue of Immunity, Okoye et al.
(2014) add to this list another mechanism
of suppression, that of nonautonomous
gene silencing mediated by miRNA-
containing exosomes. Exosomes are 40–
100 nM vesicles that are generated by
the inward invagination of endosomal
membranes to generate intraluminal vesi-
cles in multivesicular bodies (Raposo and
Stoorvogel, 2013). The latter are traffickedto the cell membrane by a Rab family
GTPase-dependent mechanism where
the exosomes are released. Exosome
formation may proceed by a mechanism
involving the endosomal sorting complex
for transport, a set of conserved proteins
involved in lysosomal and exosomal traf-
ficking, or by an alternative mechanism
involving lipid raft segregation in a cer-
amide-dependent manner. The capacity
of exosomes to transfer miRNA and
mRNA has been verified in many cell
types (Robbins and Morelli, 2014). Okoye
et al. (2014) extended this concept to Treg
cells by first identifying them as prolific
producers of exosomes, whose release
was hypoxia sensitive and required
Rab27a and Rab27b GTPases and cer-
amide. Importantly, Treg cell exosomes
were laden with miRNA, the profile
of which was distinct from those of Th1
and Th2 cells. The authors directly
demonstrate that Treg cell exosomesnity 41, July 17, 2014 ª2014 Elsevier Inc. 3
Figure 1. Treg Cell Exosomes Suppress Th1 Cell Responses
Cytokines and metabolic factors regulate Treg cell exosome release. Exosome generation and export de-
pends upon ceramide and Rab GTPases (Rab27a, Rab27b), respectively. Delivery of exosomes
containing the miRNA Let-7d to Th1 effector cells results in suppression of proliferation and cytokine
secretion.
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Previewstransferred a specific set of miRNA to
conventional T cells, including miR-155,
Let-7b, and Let-7d, both in vitro and
in vivo. Compromised transfer of Treg
cell exosomal miRNAs to conventional
T cells, either because of failed miRNA
formation (Treg cell Dicer deficiency) or
exosome release (Treg cell Rab27a- and
Rab27b-deficient Treg cells), abrogated
the capacity of Treg cells to prevent
disease in a lymphopenia-induced model
of colitis.
Okoye et al. (2014) went on to demon-
strate a specific role for exosomes
in regulating Th1 cell responses (Figure 1).
Purified exosomes fromWT but not Dicer-
deficient Treg cells added to in vitro Th1
cell cultures suppressed cell proliferation
and IFN-g production. Of the threemature
exosomal Treg cell miRNAs that were
identified in conventional T cells, Let-7d
was specifically associated with the con-
trol of Th1 cell responses both in vitro
and in vivo. Treg cells transfected with
a Let-7d inhibitor were compromised
in their capacity to suppress Th1 cell
proliferation and interferon-g (IFN-g) pro-
duction in vitro and suppress colonic
inflammation and IFN-g expression by
conventional T cells in the lymphopenia
colitis model.
Employment by Treg cells of miRNA-
mediated nonautonomous gene silencing
as a suppressive mechanism offers
several advantages. It redirects the tran-
scriptional circuitry and cellular function
of recipient conventional T cells in favor4 Immunity 41, July 17, 2014 ª2014 Elsevierof a tolerogenic profile. As such, it is a
particularly effective mediator of ‘‘infec-
tious tolerance,’’ where the effects may
range from the transient to the long last-
ing. Although the studies of Okoye et al.
(2014) were focused on the inhibition of
Th1 cells by Treg cell exosome miRNA,
this mechanism is well suited to context-
dependent regulation of other Th cell
responses. Specificity for a particular Th
cell response may be tailored by the pre-
cise combination of miRNA delivered by
Treg cell exosomes. Sensitivity of exo-
some release to hypoxia adds a further
layer of control that may fine-tune exo-
some release in different regions of the
gastrointestinal tract.
In addition to miRNA, exosomes also
deliver other noncoding RNA,mRNA, pro-
teins, and lipids that have been implicated
in immune regulation (Robbins and Mor-
elli, 2014). Okoye et al. (2014) demon-
strate awide range of transcripts enriched
in Treg cell exosomes as compared to
the parent cells, including those encoding
chemokines, interleukins, collagen and
matrix proteins, ephrins, and others. The
role of Treg cell exosomal mRNA and pro-
teins in modulating target cells remains
unknown but seems likely to play a role
in their immunomodulatory effects.
There are some caveats to the studies
of Okoye et al. (2014), principle among
which is the lack of clarity surrounding
the differential contribution of nonautono-
mous gene silencing to Treg-cell-medi-
ated regulation as compared to otherInc.well-established suppressive mecha-
nisms. Most of the in vivo observations
on the role of this pathway in peripheral
tolerance were gleaned from studies us-
ing the lymphopenia-colitis model, which
suffers from the limitations of an immuno-
deficient host and a lymphopenic envi-
ronment. Additionally, Treg-cell-specific
ablation of RNaseIII enzymes involved
in miRNA maturation, including Dicer
andDrosha, results in rapidly fatal autoim-
munity, whereas Rab27a and Rab27b
double-deficient mice lacking in Treg cell
exosome release suffer a relatively mild
inflammatory phenotype (Chong et al.,
2008; Liston et al., 2008). These observa-
tions, although arguing for a dominant
cell-intrinsic role for miRNA in controlling
Treg cell functions, also hint at a more
focused role for exosomal delivery of
miRNA and other molecules in peripheral
tolerance such as context-specific
Th cell regulation and maintenance
of mucosal tolerance. Studies employ-
ing Treg-cell-lineage-specific genetic
approaches that target the exosomal
pathway in other disease models and
rescue experiments of Foxp3-deficient
mice with exosome-sufficient or -defi-
cient Treg cells may further clarify the
role of this pathway in peripheral toler-
ance. Its differential role in natural (thymic)
versus induced Treg (iTreg)-cell-medi-
ated tolerance is also relevant, given the
importance of the latter for mucosal
tolerance.
Although the work of Okoye et al. (2014)
centered on the regulation of T effector
cell responses, it is easy to envision how
Treg cell exosomes might impact the reg-
ulatory compartment. In an inflammatory
environment, sentinel Treg cells might
‘‘educate’’ newly recruited Treg cells.
For example, exosome-mediated transfer
of miRNA-155 would decrease SOCS1
expression and increase STAT5 activa-
tion, based on data from Treg-cell-
specific ablation of miRNA-155 (Lu
et al., 2009). The result would favor Treg
cell homeostasis and stability. Similarly,
enhancement of TGF-b signaling path-
ways in conventional T cells might in-
crease iTreg cell production. Overall, the
results of Okoye et al. (2014) foretell
a number of immunoregulatory effects
offered by Treg-cell-mediated exosomal
delivery of miRNA and other agents
that will surely be the subject of future
investigations.
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Macrophage and dendritic cell (DC) progenitors (MDPs) produce macrophages and DCs but not other
hematopoietic lineages. In this issue of Immunity, Sathe et al. (2014) show that isolated MDP populations
hardly contain such bipotent progenitors at clonal levels, arguing against the existence of MDPs.Macrophages and dendritic cells (DCs)
scavenge dying cells and pathogens by
phagocytosis and endocytosis, thereby
contributing to tissue homeostasis.
Because these cells share similar cell sur-
face makers and functions, their develop-
mental origin and relationship have been
subject to debate. Recent studies indi-
cated that some macrophages in adult
tissues such as brain, liver, and epidermis
are derived from embryonic precursors
before birth, whereas other macrophages
in the intestine, heart, lung, and dermis
are of monocyte origin. Under inflamma-
tory conditions, monocytes are converted
to DCs (monocyte-derived DCs) and tis-
sue-resident macrophages. Monocytes
and DCs are derived from hematopoietic
stem cells (HSCs) in the bone marrow
(BM) through intermediate progenitors.
By sequentially losing the breadth of their
differentiation potential, multipotent pro-
genitors eventually become progenitors
committed to specific hematopoietic line-
ages. Macrophage and DC progenitors
(MDPs), which give rise to monocytes-macrophages and DCs but not to other
hematopoietic lineages, were proposed
to exist in mouse BM (Fogg et al., 2006).
MDPs are distinguished from granulocyte
macrophage progenitors (GMPs) by their
expression of the chemokine receptor
CX3CR1 (Fogg et al., 2006). In addition,
common DC progenitors (CDPs) are
strictly committed to resident conven-
tional DCs (cDCs) and plasmacytoid DCs
(pDCs) (Naik et al., 2007; Onai et al.,
2007, 2013). Based on their develop-
mental potential and lineage commit-
ment, GMPs were thought to develop
into MDPs by losing their granulocyte
potential and further into CDPs and
common monocyte progenitors (cMoPs)
(Hettinger et al., 2013). Supporting the
MDP-to-CDP axis, MDPs injected into
BM develop into c-kitint/lo CDP-like cells,
although the developmental potential of
these CDP-like cells was not evaluated
(Liu et al., 2009). Therefore, MDPs have
been generally accepted as the branch
point of DC versus monocyte-macro-
phage development (Figure 1).In this issue of Immunity, Sathe et al.
(2014) describe the developmental rela-
tionship of resident DCs and macro-
phages. Lymphoid-tissue-resident DCs
consist of cDCs and pDCs, and in mice
the cDCs are further divided into CD8a+
Clec9A+ and CD8aClec9A subpopula-
tions. Sathe et al. (2014) isolated MDPs
based on the original definition, linc-kithi
sca-1CD16/32hiCX3CR1
+ (Fogg et al.,
2006) and linM-CSFR+ (Waskow et al.,
2008). Adoptive transfer experiments
confirmed that the MDPs gave rise to
monocytes-macrophages, the resident
cDC subpopulations CD8a+Clec9A+ and
CD8aClec9A, and pDCs in the spleen.
However, in contrast to previous findings
(Fogg et al., 2006; Hettinger et al., 2013),
these MDPs also generated significant
amounts of Ly6G+ granulocytes, which
was confirmed by colony-forming assays.
Of the colonies produced from individual
MDPs, 20%–40% were granulocyte col-
onies, indicating that the MDPs contained
substantial amounts of granulocyte-pro-
ducing clones. Why MDPs showed littlenity 41, July 17, 2014 ª2014 Elsevier Inc. 5
